MONTANIDE IMS 1313 VG NST

SECTION 2: Hazards identification

Classification according to Regulation (EC) No. 1272/2008 [CLP/GHS]] Directive 1999/45/EC: Classification of the substance or mixture

Signal word

No signal word.

Hazard statements

No known significant effects or critical hazards.

Precautionary statements

Additional warning Bafety data sheet available on request. phrases

Other hazards which do not result in classification

Rone known.

Additional information

Handling REHOMOGENISE BEFORE USE. For veterinary use only. IF 2 PHASES, HOMOGENISE AT 30°C. Revision > 07/11/2013. 1/9

Storage

- KEEP AWAY FROM LIGHT/FROST/HEAT/UNDER NITROGEN.

2.1 Classification of the substance or mixture

Classification according to Regulation (EC) No. 1272/2008 [CLP/GHS] Not classified. Classification according to Directive 1999/45/EC [DPD] The product is not classified as dangerous according to Directive 1999/45/EC and its amendments. Classification : Not classified. See Section 16 for the full text of the R phrases or H statements declared above. See Section 11 for more detailed information on health effects and symptoms. 2.2 Label elements Signal word : No signal word. Hazard statements : No known significant effects or critical hazards. Precautionary statements Additional warning : Bafety data sheet available on request. phrases 2.3 Other hazards Other hazards which do : Rone known. not result in classification ADDITIONAL INFORMATION Handling : REHOMOGENISE BEFORE USE. For veterinary use only. IF 2 PHASES, HOMOGENISE AT 30°C. Date of issue/Date of revision > 07/11/2013. 1/9 Complying with 1907/2006/EC, 1272/2008/EC and 453/2010/EC regulations - United Kingdom (UK) SECTION 2: Hazards identification Storage - KEEP AWAY FROM LIGHT/FROST/HEAT/UNDER NITROGEN. SECTION 3: Composition/information on ingredients Substance/mixture : Mixture Product description : Anhydro mannitol ether octodecenoate. Solution, In water, Oily. Classification Productiingredient Identifiers % 67/548/EEC Regulation (EC) No. Type name 1272/2008 [CLP] White mineral oil REACH #: 5-10 |Not classified. Asp. Tox. 1, H304 (i (petroleum) 01-2119487078-27 EC: 232-455-8 monosaccharide - 1-10 [Xi R36 Eye Irrit. 2, H319 (1] derivative, salt See Section 16 for See Section 16 for the the full text of the R- full text of the H phrases declared statements declared above. There are no additional ingredients present which, within the current knowledge of the supplier and in the concentrations applicable, are classified as hazardous to health or the environment, are PBTs or vPvBs or have been assigned a workplace exposure limit and hence require reporting in this section. Type fl Substance classified with a health or environmental hazard [2] Substance with a workplace exposure limit [3] Substance meets the criteria for PBT according to Regulation (EC) No. 1907/2006, Annex XHi [4] Substance meets the criteria for vVPVB according to Regulation (EC) No. 1907/2006, Annex XIll [5] Substance of equivalent concern Occupational exposure limits, if available, are listed in Section 8. SECTION 4: First aid measures 4.1 Description of first aid measures Eye contact : Immediately flush eyes with plenty of water, occasionally lifting the upper and lower eyelids. Check for and remove any contact lenses. Get medical attention if irritation occurs. Inhalation : Remove victim to fresh air and keep at rest in a position comfortable for breathing. Get medical attention if symptoms occur. Skin contact : Flush contaminated skin with plenty of water. Remove contaminated clothing and shoes. Get medical attention if symptoms occur. Ingestion : Wash out mouth with water. Remove victim to fresh air and keep at rest in a position comfortable for breathing. If material has been swallowed and the exposed person is conscious, give small quantities of water to drink. Do not induce vomiting unless directed to do so by medical personnel. Get medical attention if symptoms occur. Protection of first-aiders : No action shall be taken involving any personal risk or without suitable training. 4.2 Most important symptoms and effects, both acute and delayed